// App-Quantinova.ai

TCT-223 : A randomized, placebo controlled, double-blind, phase 4 study to evaluate efficacy and safety of triple anti-platelet therapy compared with dual antiplatelet therapy in patients treated with drug-eluting stent for coronary artery disease

Researchers

Presenter

  • Cheol Hyun Lee

Principal Investigators

  • Osung Kwon

  • Ungjeong Do

  • Jung-Min Ahn

  • Jung Ae Hong

  • Kyusup Lee

  • Min Soo Cho

  • B.A.E. Jaeseok

  • Do-Yoon Kang

  • Se Hun Kang

  • Pil Hyung Lee

  • Sung-Han Yoon

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Coronary Artery Disease

  • Myocardial infarction

  • Ischemic stroke

  • Venous thrombosis

  • Restenosis

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Clopidogrel bisulfate

  • cilostazol

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • IV

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved